Aversi Pharma described 2025 as another year of planned growth, according to Levan Kurtanidze, a member of the company’s Board of Directors, during a guest appearance on TV-program Business Morning. Kurtanidze noted that the company expanded its non-medication product lines, aligning with international trends in pharmacy development.
“We measure success by having more satisfied customers and grateful, recovered patients than the previous year. That’s how we grow annually, and 2025 is a clear example. We implemented specific projects in both pharmacies and clinics, which will allow us to grow further in the future,” he said.
Kurtanidze explained that Aversi’s pharmacies are expanding primarily in self-care products, including dermatological brands, child care items, nutrition, accessories, and more. He emphasized that this trend is driven by customer trust in pharmacies, which maintain high service and storage standards, encouraging demand for a broader range of products.
In addition, 2025 marked the year Aversi fully equipped its pharmacies with self-service machines, and in 2026 the company plans to add 12 new pharmacy robots across Tbilisi and other major cities. Kurtanidze highlighted that the robots greatly assist pharmacists and improve operational efficiency.
